Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050123919A1
SERIAL NO

10505936

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides diagnostic methods and kits including oligo and/or polynucleotides or derivatives, including as well antibodies determining whether a human subject is at risk of getting adverse drug reaction after statin therapy or whether the human subject is a high or low responder or a good a or bad metabolizer of statins. The invention provides further diagnostic methods and kits including antibodies determining whether a human subject is at risk for a cardiovascular disease. Still further the invention provides polymorphic sequences and other genes. The present invention further relates to isolated polynucleotides encoding a phenotype associated (PA) gene polypeptide useful in methods to identify therapeutic agents and useful for preparation of a medicament to treat cardiovascular disease or influence drug response, the polynucleotide is selected from the group comprising: SEQ ID 1-80 with allelic variation as indicated in the sequences section contained in a functional surrounding like full length cDNA for PA gene polypeptide and with or without the PA gene promoter sequence.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SIEMENS HEALTHCARE DIAGNOSTICS GMBH65760 ESCHBORN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kallabis, Harald Koln, DE 13 162
Schwers, Stephan Koln, DE 15 30
Stropp, Udo Haan, DE 26 244

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation